There will be a ChatGPT moment for biotechnology,” a bipartisan commission wrote in the new report, which calls for the U.S.

The company has decided to switch gears following disappointing data for a monoclonal antibody targeting a rare maternal ...

We, like so many others, have been forced to take steps to extend our cash runway,” said Tango’s CEO, citing the “extremely challenging financial markets.” ...